We are live on ! Find out more
RBFC

Roman Butler Fullerton & Co Portfolio holdings

AUM $364M
1-Year Est. Return 27.64%
This Fund
S&P 500
This Quarter Est. Return
-3.72%
1 Year Est. Return
+27.64%
3 Year Est. Return
+108.65%
5 Year Est. Return
+154.92%
10 Year Est. Return
–
AUM
$157M
AUM Growth
-$22.8M
Cap. Flow
-$11.8M
Cap. Flow %
-7.51%
Top 10 Hldgs %
28.08%
Holding
185
New
10
Increased
91
Reduced
50
Closed
16

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.15M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$1.07M
3
MOH icon
Molina Healthcare
MOH
+$983K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$888K
5
LNG icon
Cheniere Energy
LNG
+$796K

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.1M
2
UTHR icon
United Therapeutics
UTHR
+$1.57M
3
MSFT icon
Microsoft
MSFT
+$1.46M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.41M
5
FNCL icon
Fidelity MSCI Financials Index ETF
FNCL
+$971K

Sector Composition

Rank Sector Weight
1 Technology 16.56%
2 Healthcare 15.78%
3 Financials 8.85%
4 Consumer Staples 7.56%
5 Consumer Discretionary 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.48T
$8.16M 5.19%
58,711
-812
-1% -$127K
MSFT icon
2
Microsoft
MSFT
$3.64T
$6.99M 4.44%
31,002
-5,537
-15% -$1.46M
AMZN icon
3
Amazon
AMZN
$3.06T
$5.07M 3.23%
45,202
+565
+1% +$71.4K
MA icon
4
Mastercard
MA
$503B
$4.8M 3.05%
16,794
-511
-3% -$169K
VIG icon
5
Vanguard Dividend Appreciation ETF
VIG
$112B
$3.54M 2.25%
26,071
+35
+0.1% +$5.21K
LLY icon
6
Eli Lilly
LLY
$999B
$3.54M 2.25%
10,808
-1,853
-15% -$587K
PFF icon
7
iShares Preferred and Income Securities ETF
PFF
$13.2B
$3.32M 2.11%
107,045
+382
+0.4% +$12.8K
PG icon
8
Procter & Gamble
PG
$336B
$2.99M 1.9%
24,061
-4,219
-15% -$599K
FTCS icon
9
First Trust Capital Strength ETF
FTCS
$7.85B
$2.92M 1.86%
43,242
+548
+1% +$39.4K
GOOG icon
10
Alphabet (Google) Class C
GOOG
$4.57T
$2.83M 1.8%
28,840
+1,400
+5% +$156K
NOBL icon
11
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.7B
$2.64M 1.68%
64,896
+800
+1% +$35.4K
HD icon
12
Home Depot
HD
$338B
$2.64M 1.68%
9,323
+241
+3% +$71.1K
BRK.B icon
13
Berkshire Hathaway Class B
BRK.B
$1.1T
$2.61M 1.66%
9,756
+146
+2% +$41.5K
EOI
14
Eaton Vance Enhanced Equity Income Fund
EOI
$818M
$2.22M 1.41%
154,647
+13,971
+10% +$220K
PFE icon
15
Pfizer
PFE
$143B
$2.21M 1.41%
52,799
+2,211
+4% +$107K
JNJ icon
16
Johnson & Johnson
JNJ
$614B
$1.89M 1.2%
11,602
+251
+2% +$42.5K
WMT icon
17
Walmart Inc
WMT
$880B
$1.82M 1.16%
41,259
+318
+0.8% +$13.9K
VRTX icon
18
Vertex Pharmaceuticals
VRTX
$120B
$1.77M 1.13%
6,005
-602
-9% -$173K
VUG icon
19
Vanguard Morningstar Growth ETF
VUG
$226B
$1.64M 1.04%
46,746
-1,134
-2% -$45.6K
PANW icon
20
Palo Alto Networks
PANW
$281B
$1.63M 1.03%
20,666
-10,798
-34% -$935K
GOOGL icon
21
Alphabet (Google) Class A
GOOGL
$4.58T
$1.58M 1%
16,225
-12,695
-44% -$1.41M
HUM icon
22
Humana
HUM
$44.2B
$1.54M 0.98%
3,097
-413
-12% -$201K
NDAQ icon
23
Nasdaq
NDAQ
$52.9B
$1.53M 0.97%
26,394
-63
-0.2% -$3.71K
ETW
24
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.04B
$1.49M 0.94%
187,679
+17,517
+10% +$153K
XLV icon
25
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
$1.47M 0.93%
11,959
+127
+1% +$16.4K
1
2 3 4 5

Similar funds

EW
Evexia Wealth Stevens Point, Wisconsin $364M AUM 29.61% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
RGC
Roberts, Glore & Co Deerfield, Illinois $364M AUM 19.54% 1-Year Est. Return
DCP
Davern Capital Partners Ny, New York $365M AUM
SWA
Strata Wealth Advisors Dallas, Texas $365M AUM 16.8% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $363M AUM 34.89% 1-Year Est. Return
RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Roman Butler Fullerton & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Roman Butler Fullerton & Co held 185 positions worth $157M, down 13% from $180M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Roman Butler Fullerton & Co withdrew a net $11.8M in Q3 2022, closing 16 positions and reducing 50 holdings. Its most notable exit was United Therapeutics, an estimated $1.57M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Roman Butler Fullerton & Co opened a new position in Regeneron Pharmaceuticals worth $1.35M.

  • Roman Butler Fullerton & Co's largest Q3 2022 buy was Regeneron Pharmaceuticals: 1,826 shares worth $1.35M.
  • Roman Butler Fullerton & Co added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $888K increase.
  • Roman Butler Fullerton & Co's biggest Q3 2022 reduction was NVIDIA, cutting an estimated $2.1M.
  • Roman Butler Fullerton & Co fully exited United Therapeutics in Q3 2022, selling an estimated $1.57M.
  • Roman Butler Fullerton & Co's ten largest holdings make up 28% of its $157M portfolio in Q3 2022.
  • Roman Butler Fullerton & Co opened 10 new positions and closed 16 in Q3 2022.
  • Roman Butler Fullerton & Co's portfolio value fell 13% quarter-over-quarter to $157M.

Based on Roman Butler Fullerton & Co's 13F filing for Q3 2022, filed 17 Oct 2022.